Quvara Medical

Executive Summary

Quvara Medical is a UK-based contract manufacturing organization (CMO) with over 30 years of operational expertise in high-volume production of regulated drug-delivery devices, including autoinjectors and pen injectors. Founded in 2019 and operating from a facility in Swindon, the company provides end-to-end manufacturing and technical support to pharmaceutical and biotech partners. Its core value proposition lies in platform-based manufacturing, robust quality systems, and regulatory compliance, enabling reliable and scalable supply for injectable therapies. As a private entity with no disclosed fundraising, Quvara operates in a high-demand niche driven by the growth of biologics and self-administered drugs. The company's established track record and focus on compliance position it as a trusted partner for drug developers seeking to commercialize and scale their products. With the global autoinjector market expected to grow significantly, Quvara Medical is well-placed to capture market share through its specialized capabilities and long-standing industry relationships.

Upcoming Catalysts (preview)

• Q3 2026Major partnership with a top-20 pharma for platform-scale production60% success
• Q4 2026Expansion of Swindon facility capacity to meet growing demand70% success
• Q2 2026Achievement of key regulatory certifications (e.g., MDR compliance)85% success